Hercules Capital Inc Stock News

The underwriting track record at Hercules Capital, Inc. has not been spectacular - $1 of NAV in 2005 was whittled down to ~$0.75 in 2020.

Hercules Capital's business continues to rebound, with improving NAV and NII per share, and improving credit quality on its portfolio investments.

These dividend stocks have juicy dividends, but are also strong, reliable companies in their own right and should be on your short list. The post 4 Big Dividends to Be Thankful For appeared first on I

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) today announced a private offering totaling $100.0 million in aggregate principal amount o

Hercules Capital, Inc. (HTGC) CEO Scott Bluestein on Q3 2020 Results - Earnings Call Transcript

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and es

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and est

This is a series of articles discussing retirement portfolios using BDCs currently yielding around 12% and their safer notes - baby bonds/preferred shares with yield-to-maturities ranging from 6% to 1

This is a series of articles discussing retirement portfolios using BDCs currently around 12% and their safer notes - baby bonds/preferred shares with yield-to-maturities ranging from 6% to 10%.

Horizon Technology and Finance is an externally managed business development company. While onboarding yields are down, net investment income is up when compared to both the first quarter of 2020 and

Horizon Technology Finance is an externally-managed BDC that is focused on lending to life sciences and technology companies.

Hercules Capital is a leading internally-managed BDC that focuses on venture debt investments in technology, life sciences, and renewable technology industries.

The government's PPP loan program is a boon to NEWT. Small Business Administration (SBA) loan payments help insure a steady income for NEWT.

AVEO Oncology (Nasdaq: AVEO) today announced the closing of a tranched, $35 million debt facility with Hercules Capital, Inc. (NYSE: HTGC) and its aff

Stealth BioTherapeutics Corp (NASDAQ:MITO) Q2 2020 Earnings Conference Call August 6, 2020 8:30 AM ET Company Participants Henry Hess - Chief Legal Counsel Reenie McCarthy - Chief Executive Officer Ro